National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G03AD01	EZ-ONE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet	722,987 L.L
G03AD02	ECINQ	G	Ulipristal acetate - 30mg	30mg	Tablet, film coated	1,302,183 L.L
L01CA04	EBERELBIN	G	Vinorelbine (tartrate) - 50mg/5ml	50mg/5ml	Injectable concentrated solution	6,834,783 L.L
L01CB01	ETOPOSIDE EBEWE	G	Etoposide - 100mg/5ml	100mg/5ml	Injectable concentrated solution	768,678 L.L
C01CA03	EPINORD	G	Noradrenaline (tartrate) - 8mg/4ml	8mg/4ml	Injectable solution	2,751,678 L.L
L01CB01	ETOPOSIDE VIATRIS 20MG/ML	G	Etoposide - 100mg/5ml	100mg/5ml	Injectable concentrated solution	1,544,466 L.L
L01CD01	EBETAXEL	G	Paclitaxel - 30mg/5ml	30mg/5ml	Injectable concentrated solution	2,983,330 L.L
L01CD01	EBETAXEL	G	Paclitaxel - 150mg/25ml	150mg/25ml	Injectable concentrated solution	15,457,059 L.L
C01CA26	EPHEDRINE AGUETTANT	G	Ephedrine HCl - 30mg/ml	30mg/ml	Injectable solution	614,136 L.L
L04AX03	EBETREXAT	G	Methotrexate - 5mg	5mg	Tablet, scored	2,488,796 L.L
C01CA26	EPHEDRINE RENAUDIN	G	Ephedrine HCl - 30mg/ml	3%	Injectable solution	693,423 L.L
C01CA26	EPHEDRINE AGUETTANT	G	Ephedrine HCl - 3mg/ml	3mg/ml	Injectable solution	7,827,491 L.L
L04AX03	EBETREXAT	G	Methotrexate - 15mg/1.5ml	15mg/1.5ml	Injectable solution	2,135,366 L.L
J01DH03	ERTANZ	G	Ertapenem - 1g	1g	Injectable powder	2,521,049 L.L
S01ED51	EPISOPT	G	Timolol - 5mg, Dorzolamide HCl - 20mg		Drops	575,165 L.L
J01DH03	ERTAPENEM ARROW	G	Ertapenem - 1g	1g	Injectable concentrate for solution	2,650,057 L.L
L04AX04	ERVALI	G	Lenalidomide - 5mg	5mg	Capsule, hard	37,370,561 L.L
J01DH03	ERTAPENEM INJECTION	G	Ertapenem - 1g	1g	Injectable concentrate for solution	26,153,163 L.L
N02BE51	EXTRA STRENGTH HEADACHE RELIEF	G	Acetaminophen - 250mg, Acetylsalicylic acid - 250mg, Caffeine - 65mg		Tablet	353,431 L.L
B05BB02	ELECTROLYE 67	G	Calcium gluconate - 0.10g/100ml, Potassium chloride - 0.075g/100ml, Sodium chloride - 0.30g/100ml, Dextrose, H2O - 5.0g/100ml		Injectable solution	165,727 L.L
N06DA52	EXENTAZIL	G	Donepezil - 10mg, Memantine - 28mg		Capsule	4,363,009 L.L
L04AX04	ERVALI	G	Lenalidomide - 10mg	10mg	Capsule, hard	71,493,520 L.L
J05AF10	ENTECAVIR ARROW	G	Entecavir - 1mg	1mg	Tablet, coated	18,701,506 L.L
N06DA52	EXENTAZIL	G	Donepezil - 10mg, Memantine - 14mg		Capsule	3,117,715 L.L
J05AF10	ENTECAVIR BIOGARAN	G	Entecavir - 1mg	1mg	Tablet, coated	19,080,319 L.L
L02BB04	ENZASTIK 40	G	Enzalutamide - 40mg	40mg	Capsule	L.L
A10BD19	EMPAGLINE	G	Empagliflozin - 10mg, Linagliptin - 5mg		Tablet, film coated	2,237,050 L.L
J05AF10	ENTRILIV	G	Entecavir - 1mg	1mg	Tablet, film coated	19,165,898 L.L
N06DX01	EXENTA	G	Memantine HCl - 10mg	10mg	Tablet, film coated	1,057,156 L.L
A10BD19	EMPAGLINE	G	Empagliflozin - 25mg, Linagliptin - 5mg		Tablet, film coated	2,237,050 L.L

...